Coronavirus in Russia: The Latest News | Sept. 24

Russia has confirmed 1,128,836 cases of coronavirus and 19,948 deaths. Sept. 24: What you need to know today Russia confirmed 6,595 new Covid-19 cases Thursday, bringing the country’s official number of cases to 1,128,836 as the number of new infections across the country continues to rise. Moscow confirmed more than 1,000 coronavirus cases for the first time since June…

Russia’s Coronavirus Drug to Be Sold in 23 Countries

Russia’s coronavirus treatment drug Avifavir will be made available in 17 more countries in addition to the six countries where it is already sold, Russia’s sovereign wealth fund said in a statement Thursday.  Avifavir, manufactured by Russia’s ChemRar biotechnology firm, was the world’s first drug to be registered for coronavirus treatment. Belarus, Bolivia, Kazakhstan, Kyrgyzstan, Turkmenistan…

Russia Seizes Kremlin Critic Navalny’s Apartment

Russian authorities have seized Kremlin critic Alexei Navalny’s apartment days after he was discharged from German hospital where he was being treated for poisoning by Novichok, his spokeswoman said Thursday.  Kira Yarmysh said court marshals came after Navalny’s three-bedroom apartment in southeastern Moscow to enforce a $1-million court ruling in favor of catering magnate Yevgeny…

Gazprom approves programs for reconstruction and re-equipment of gas production and transmission facilities for years 2021–2025

September 24, 2020, 15:25 The Gazprom Management Committee approved the 2021–2025 comprehensive programs for the reconstruction and re-equipment of gas production and transmission facilities. The documents aim to provide for high reliability and operational safety of Russia’s Unified Gas Supply System, as well as fulfillment of obligations on gas supplies by the Company to consumers in the domestic and external markets. Specifically, the top priority in the area of production is, as before, to achieve maximum production rates during…

Russia’s 2nd Potential Coronavirus Vaccine Nears Approval

Russia’s second candidate vaccine against the coronavirus is less than a month away from state approval after completing small-scale human trials, the vaccine’s developers have said this week.  The Siberia-based Vektor State Virology and Biotechnology Center concluded Phase 2 trials on 100 volunteers last week, with results due to be published Wednesday. Volunteers were said…

New Virus Cases in Moscow Climb to June Levels

New coronavirus cases in Moscow on Thursday reached the highest level since late June, raising fears of a new wave of cases in the world’s fourth most affected country. The caseload increase had remained relatively stable in the capital at around 700 per day for several months, but the numbers began to climb again from…